Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

A Study of ZEN003694 in People With Squamous Cell Lung Cancer

NCT05607108

Conditions
Disease Attributes, Neoplasm Metastasis, Neoplasms, +5 more
Locations
  • Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

68Ga-PSMA PET in the Renal Cell Carcinoma

NCT04987086

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +15 more
Locations
  • The First Hospital of Lanzhou University Lanzhou, Gansu, China
  • General Hospital of Ningxia Medical University Yinchuan, Ningxia, China
  • Qinghai University Affiliated Hospital Xining, Qinghai, China
  • Xijing Hospital Xi'an, Shaan'xi, China
View Trial Details
Recruiting

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

NCT04333706

Conditions
Breast, Cancer, Disseminated Tumor Cell, +7 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UF Health Gainesville, Florida, United States
View Trial Details
Recruiting

ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

NCT06951646

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Hunan Cancer Hospital Changsha, China
  • The Second Xiangya Hospital of Central South University Changsha, China
  • The Third Hospital of Changsha Changsha, China
  • Xiangya Hospital of Central South University Changsha, China
View all 20 locations
View Trial Details
Recruiting

Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma

NCT07057596

Conditions
Melanoma, Mestastatic Uveal Melanoma, Neoplasm Metastasis, +14 more
Locations
  • Charité - Universitätsmedizin Berlin Berlin, State of Berlin, Germany
  • Institut Catala d'Oncologia (ICO) Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital La Paz Madrid, Spain
  • Consorcio Hospital General Universitario de Valencia Valencia, Spain
View Trial Details
Recruiting

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

NCT06171750

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +23 more
Locations
  • National Cancer Institute Bethesda, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Providence Cancer Institute Portland, Oregon, United States
  • Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population

NCT05708235

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Complejo Hospitalario Universitario A Coruña (CHUAC) A Coruña, Spain
  • Hospital General Universitario Dr. Balmis Alicante, Spain
  • Hospital Marina Salud de Denia Alicante, Spain
  • Hospital Virgen de los Lirios Alicante, Spain
View all 41 locations
View Trial Details

Related conditions